HILPDA, CD24, TCF3, SERPINE1, INHBA, P4HA2 and ACTN1 can be used to predict the response of locally advanced HPV-negative HNSCC patients receiving postoperative chemoradiation [32]. This evidence concerns the gene CD24 and head and neck squamous cell carcinoma.